VM
Vanessa Malier
Managing Partner at Kurma Partners
Greater Paris Metropolitan Region
Overview
Vanessa Malier is a highly accomplished executive in the biotech and pharma industry, currently serving as the Managing Partner at Kurma Partners, where she leads investments in healthcare startups at various stages, including Series A, Series B, and Seed. With an impressive background in strategic planning, business development, and clinical development, Vanessa has held key leadership roles at Ipsen, where she served as Vice President of R&D Strategic Planning and led various corporate business development initiatives, contributing significantly to the company's growth and success.
Work Experience
Chairman of the Board
2025 - Current
Executive Chairman
2024 - 2025
Strategic Advisor
2023 - 2024
Non Executive Director
2023
Strategic Advisor
2024 - 2025
Worked closely with Antag CEO, Chairman and Lead investor on the 80m€ Series A led led by Versant with participation from founding investor Novo Holdings and new investors SR One, Dawn Biopharma and Pictet
Managing Partner
2015 - 2023
Kurma Partners/Eurazeo is a venture capital firm with €700m in asset under managment. I invested in and served on the Board of Asceneuron, Corlieve as a Chairman, acquired by uniQure, IO Biotech (IOBT), Step Pharma as a Chairman then Board member, Vivet Therapeutics and Xeltis.
Partner
2013 - 2014
Vice President, R&D Strategic Planning
2011 - 2013
Senior Director, Corporate Business Development
2011 - 2011
Director, Corporate Business Development Oncology
2008 - 2011
Adenuric Project Leader & International Product Manager, Corporate Strategic Marketing
2005 - 2008
GastroEnterology Strategy Team Leader
2004 - 2005
Strategic Advisor to the CEO
2003 - 2005
Business Development Manager
1999 - 2003
Analyst - Health Care
1998 - 1999
Education
DEA
1996 - 1997